8-KEarnings & ResultsExhibits & Filings

BRISTOL MYERS SQUIBB CO 8-K Report, Financial Results (Jul 28, 2005)

Filed July 28, 2005For Securities:BMYCELG-RIBMYMP

Summary

Bristol-Myers Squibb Company (BMY) filed an 8-K on July 28, 2005, to announce its financial results for the second quarter of 2005. The report primarily serves to furnish a press release and supplementary website data detailing these results. Investors should refer to the attached press release (Exhibit 99.1) and supplemental information (Exhibit 99.2) for specific financial performance figures and operational highlights from the period. This filing is a standard disclosure mechanism for reporting quarterly earnings. While the 8-K itself does not contain the detailed financial data, it directs investors to the primary sources where such information can be found. Therefore, the substance of the investor takeaway lies within the content of the referenced press release and website information, which would typically cover revenue, earnings per share, segment performance, and outlook.

Key Highlights

  • 1BMY filed an 8-K on July 28, 2005, to report Q2 2005 financial results.
  • 2The filing includes a press release (Exhibit 99.1) detailing Q2 2005 financial performance.
  • 3Supplemental financial information is also provided via Exhibit 99.2 from the company's website.
  • 4The report's primary purpose is to make Q2 2005 financial results officially public record via SEC filing.
  • 5Investors need to review the referenced press release and supplemental information for specific financial details.
  • 6The filing date aligns with the event date, indicating timely disclosure of Q2 2005 results.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially announce and report Bristol-Myers Squibb Company's financial results for the second quarter of 2005 to the public and the SEC. It serves as a formal record of the company's performance during that period.

The actual financial results for the second quarter of 2005 are detailed in the press release furnished as Exhibit 99.1 to this 8-K filing, and in certain supplemental information provided as Exhibit 99.2, which was available on Bristol-Myers Squibb's website.

No, the 8-K form itself does not contain the detailed financial data. It directs investors to two exhibits: a press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2), where the specific financial figures, such as revenue, earnings per share, and other key performance indicators, would be presented.